pravastatin has been researched along with Complications, Pregnancy in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Contento, G; Girardi, G; Jurisic, A; Jurisic, Z; Lefkou, E; Pombo, J; Varoudi, K | 1 |
Dagklis, T; Fragakis, N; Girardi, G; Lefkou, E; Mamopoulos, A; Nounopoulos, E; Rousso, D; Vosnakis, C | 1 |
Costantine, MM | 1 |
Dagklis, T; Girardi, G; Lefkou, E; Mamopoulos, A; Rousso, D; Vosnakis, C | 1 |
4 other study(ies) available for pravastatin and Complications, Pregnancy
Article | Year |
---|---|
Triple therapy with pravastatin, low molecular weight heparin and low dose aspirin improves placental haemodynamics and pregnancy outcomes in obstetric antiphospholipid syndrome in mice and women through a nitric oxide-dependent mechanism.
Topics: Adult; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Anticoagulants; Antiphospholipid Syndrome; Aspirin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fetal Growth Retardation; Hemodynamics; Heparin, Low-Molecular-Weight; Humans; Mice; Mice, Inbred C57BL; Nitric Oxide; Placenta; Pravastatin; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome | 2020 |
Clinical improvement and successful pregnancy in a preeclamptic patient with antiphospholipid syndrome treated with pravastatin.
Topics: Adult; Antiphospholipid Syndrome; Blood Pressure; Comorbidity; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Pre-Eclampsia; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Treatment Outcome | 2014 |
Pravastatin to prevent obstetrical complications in women with antiphospholipid syndrome.
Topics: Antiphospholipid Syndrome; Aspirin; Female; Humans; Pravastatin; Pre-Eclampsia; Pregnancy; Pregnancy Complications | 2016 |
Pravastatin improves pregnancy outcomes in obstetric antiphospholipid syndrome refractory to antithrombotic therapy.
Topics: Adult; Antiphospholipid Syndrome; Endothelium; Enoxaparin; Female; Fibrinolytic Agents; Gestational Age; Hemodynamics; Heparin, Low-Molecular-Weight; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Risk Factors; Tinzaparin; Uterine Artery | 2016 |